Nath Bio-Genes (I)

quarterly
yearly
ParticularsMar '22Jun '22Dec '22Mar '23Jun '23
Revenue27.94209.3925.3645.25235.40
Expenses52.03178.4623.3243.57201.99
EBITDA-20.5834.485.674.1936.93
EBIT-110.4133.805.003.2036.16
Profit Before Tax-112.8830.932.051.6733.40
Net Profit-116.3430.761.351.4433.18
Financial Ratios
Operating Profit Margin16.47%22.78%22.41%9.31%15.70%
Net Profit Margin14.69%6.76%5.34%3.22%14.11%
Earning Per Share (Diluted)-61.2216.180.710.7717.47
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ